Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). MS is primarily a disease of young adults, particularly women, with disease onset typically occurring between the ages of 20 and 40 years. Evidence suggests that MS is, in part, an autoimmune disease directed against protein components of myelin. Although not usually reported in pediatric patients, MS affects more girls than boys, and most cases are relapsing-remitting multiple sclerosis (RRMS).
Most people with MS start out with a clinical course characterized by episodes or attacks (relapses) of neurologic dysfunction, which occur over many years. This is called the relapsing-remitting phase. Symptoms of such relapses include vision loss or double vision, numbness/tingling in the extremities, muscle weakness, slurred speech, difficulty with coordination, and bladder dysfunction. Early on, these symptoms tend to subside completely after each attack. Over time, there tends to be incomplete recovery from such attacks. Most patients develop progressive disability, with or without occasional relapses, minor remissions, and plateaus.
Limited approved MS therapies are currently available for children. Meridian is conducting a clinical research study for an investigational medication for children with MS.
Must be aged 10 to <18
Must be diagnosed with multiple sclerosis
Must have experienced…
One or more relapses in the 12 months before joining OR
Two or more relapses in the 24 months before joining OR
Have evidence of asymptomatic disease activity (Gd-enhancing lesions) on brain MRI in the 6 months before joining.
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for your child.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.
Meridian Clinical Research
6161 Kempsville Circle #315
Norfolk, VA 23502
After you submit your information, a Meridian enrollment specialist will contact you.
Participating in a study is an important decision — we’re here to help you before, during, and after studies.
Please note: Health insurance is NOT required to join.
Will my child benefit from this study?
Your child is not guaranteed to benefit from being in a clinical study. However, information gathered in this study may help uncover better ways to treat condition(s) for your child and others worldwide.
Is participation voluntary after I submit my child’s information?
Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, your child’s role in the trial, potential side effects, tests that will be performed, and the number of visits required. You will need to sign an informed consent form to join the study only after you fully understand your child’s role in the study.
Will my child get a physical exam?
If you join the study, your child will receive a physical exam. Your child may also receive specific exams or tests — the results of which will be shared with you.
Is compensation provided?
While participation in a clinical study is voluntary, you may be reimbursed for your study-related travel and expenses. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible reimbursement with you.
Sign up for more information...
About Meridian Clinical Research
Founded in 1999, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.
Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For almost 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.